Nordicus Partners Corp. 10-Q Filing for June 30, 2025
Ticker: NORD · Form: 10-Q · Filed: Aug 20, 2025 · CIK: 1011060
Sentiment: neutral
Topics: 10-Q, financials, company-structure
TL;DR
**Nordicus Partners Corp. 10-Q filed: Financials for Q2 2025 out, shows stock and capital changes.**
AI Summary
Nordicus Partners Corp. filed its 10-Q for the period ending June 30, 2025. The filing includes financial data for the quarter and year-to-date, with specific details on common stock, preferred stock, additional paid-in capital, retained earnings, and treasury stock as of March 31, 2025, and June 30, 2025. The company's fiscal year ends on March 31.
Why It Matters
This filing provides investors with a quarterly update on Nordicus Partners Corp.'s financial health and capital structure, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it contains detailed financial information that requires careful analysis to assess the company's risk profile.
Key Numbers
- 0331 — Fiscal Year End (Indicates the end of the company's annual financial reporting cycle.)
- 20250630 — Reporting Period End Date (The date through which financial information is reported in this 10-Q.)
- 20250820 — Filing Date (The date this 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Nordicus Partners Corp. (company) — Filer of the 10-Q
- 20250630 (date) — End of reporting period
- 20250820 (date) — Filing date
- 0001011060 (company) — Central Index Key for Nordicus Partners Corp.
- 8742 (industry_code) — Standard Industrial Classification for Management Consulting Services
- DE (state) — State of incorporation
- 0331 (date) — Fiscal year end
- EKIMAS Corp (company) — Former company name
- AdvanSource Biomaterials Corp (company) — Former company name
- CARDIOTECH INTERNATIONAL INC (company) — Former company name
FAQ
What is the primary business of Nordicus Partners Corp.?
Nordicus Partners Corp. is classified under Standard Industrial Classification code 8742, which corresponds to Services-Management Consulting Services.
When does Nordicus Partners Corp.'s fiscal year end?
The company's fiscal year ends on March 31 (0331).
What is the reporting period for this 10-Q filing?
This 10-Q filing reports financial information for the period ending June 30, 2025 (20250630).
Has Nordicus Partners Corp. operated under different names previously?
Yes, the company was formerly known as EKIMAS Corp, AdvanSource Biomaterials Corp, and CARDIOTECH INTERNATIONAL INC.
What is the state of incorporation for Nordicus Partners Corp.?
Nordicus Partners Corp. is incorporated in Delaware (DE).
Filing Stats: 4,450 words · 18 min read · ~15 pages · Grade level 16.8 · Accepted 2025-08-19 17:41:44
Key Financial Figures
- $0.001 — Section 12(g) of the Act: Common Stock, $0.001 par value per share Indicate by check
Filing Documents
- form10-q.htm (10-Q) — 704KB
- ex31-1.htm (EX-31.1) — 12KB
- ex31-2.htm (EX-31.2) — 12KB
- ex32-1.htm (EX-32.1) — 12KB
- 0001641172-25-024884.txt ( ) — 4263KB
- nord-20250630.xsd (EX-101.SCH) — 31KB
- nord-20250630_cal.xml (EX-101.CAL) — 37KB
- nord-20250630_def.xml (EX-101.DEF) — 189KB
- nord-20250630_lab.xml (EX-101.LAB) — 281KB
- nord-20250630_pre.xml (EX-101.PRE) — 253KB
- form10-q_htm.xml (XML) — 553KB
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 20 Item 3
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 26 Item 4
Controls and Procedures
Controls and Procedures 26 PART II OTHER INFORMATION 27 Item 1.
Legal Proceedings
Legal Proceedings 27 Item 1A.
Risk Factors
Risk Factors 27 Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 27 Item 3 Defaults Upon Senior Securities 27 Item 4 Mine Safety Disclosures 27 Item 5 Other Information 27 Item 6 Exhibits 27
Signatures
Signatures 28 2 PART I - FINANCIAL INFORMATION Item 1. Unaudited Financial Statements NORDICUS PARTNERS CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS June 30, 2025 March 31, 2025 (unaudited) ASSETS Current assets: Cash $ 8,418 $ 19,914 Prepaid expenses and other current assets 153,041 37,656 Total current assets 161,459 57,570 In-process research and development 46,565,396 42,708,079 Goodwill 27,793,029 25,490,751 Investment in Mag Mile Capital, Inc. 1,550,000 1,925,000 Other assets 54,574 64,929 Total assets $ 76,124,458 $ 70,246,329 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses $ 1,619,103 $ 1,062,661 Total current liabilities 1,619,103 1,062,661 Deferred tax liability 10,244,387 9,318,414 Total liabilities 11,863,490 10,381,075 Commitments and contingencies — — Stockholders' equity: Preferred stock, Series A Junior; $ 0.001 par value; 500,000 shares authorized; no shares issued and outstanding — — Preferred stock, undesignated; $ 0.001 par value; 4,500,000 shares authorized; no shares issued and outstanding — — Preferred stock, value — — Common Stock; $ 0.001 par value; 50,000,000 shares authorized; 17,341,502 and 17,252,502 shares issued and outstanding at June 30, 2025 and March 31, 2025, respectively 17,342 17,253 Treasury stock; 154 shares at cost ( 30,328 ) ( 30,328 ) Additional paid-in capital 106,457,673 106,047,792 Accumulated other comprehensive income (loss) 5,808,015 615,385 Accumulated deficit ( 47,991,734 ) ( 46,784,848 ) Total stockholders' equity 64,260,968 59,865,254 Total liabilities and stockholders' equity $ 76,124,458 $ 70,246,329 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 3 NORDICUS PARTNERS CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE